您的位置: 首页 > 2015年9月 第46卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

12例原发性肺淋巴上皮瘤样癌的临床病理分析

Clinicopathologic analysis of 12 cases with primary lymphoepithelioma-like carcinoma of the lung

来源期刊: 广州医药 | 9-10 发布时间:2021-11-30 收稿时间:2025/11/13 16:40:56 阅读量:24
作者:
关键词:
肺淋巴上皮瘤样癌肺癌临床病理特征回顾性分析
Lung cancerLymphoepithelioma-like carcinomaPathologyRetrospective analysis
DOI:
10.3969/j.issn.1000-8535.2015.05.003
收稿时间:
2015-03-23 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 分析总结12例原发性肺淋巴上皮瘤样癌(LELC)的临床病理特点。方法 回顾性分析12例肺LELC患者的临床病理资料。结果 12例肺LELC患者的组织学标本中,肿瘤细胞均明显表达HCK,原位杂交EBER阳性率为91.7%。全组中位生存期61.3个月,2年和5年生存率分别为84.6%和57.7%。结论 原发性肺LELC临床罕见,发病可能与EB病毒感染有关,经及时治疗有较好的预后。
Objective To investigate the pathological and clinical significance of 12 cases with primary Lymphoepithelioma-like carcinoma of the lung (LELC). Methods Retrospectively detectded and analyzed the clincalpathological feature of 12 cases of LELC of the lung. Results Histological study showed that tumor cells were significantly expressed HCK by immunohistochemistry staining and showed out 91.7% positive rate of EBER by situ hybridization. In this series, the median survival time was 61.3 months. The overall 2 and 5 year survival rates of the 12 cases were 84.6% and 57.7%. Conclusion Pulmonary LELC is very rare. It may be associated with Epstein-Barr virus infection, and has a batter prognosis after therapy.
1、 陈程,陈鹏,张翠翠,等.大细胞肺癌的临床及预后分析[J]. 中华肿瘤杂志,2010, 32(12): 932-934. 陈程,陈鹏,张翠翠,等.大细胞肺癌的临床及预后分析[J]. 中华肿瘤杂志,2010, 32(12): 932-934.
2、 朱韧,刘锦铭,王亮. 109例肺大细胞癌的临床分析[J]. 临床肿瘤学杂志,2012, 17(10):912-914. 朱韧,刘锦铭,王亮. 109例肺大细胞癌的临床分析[J]. 临床肿瘤学杂志,2012, 17(10):912-914.
3、 张冬坤,苏晓东.原发性肺淋巴上皮瘤样癌的临床分析[J]. 中华肿瘤杂志,2008, 30(1):72-74. 张冬坤,苏晓东.原发性肺淋巴上皮瘤样癌的临床分析[J]. 中华肿瘤杂志,2008, 30(1):72-74.
4、 吴凯,陈昶,高文. 9例原发性肺淋巴上皮瘤样癌分析及文献回顾[J]. 中国肿瘤临床, 2010, 37(8):464-466. 吴凯,陈昶,高文. 9例原发性肺淋巴上皮瘤样癌分析及文献回顾[J]. 中国肿瘤临床, 2010, 37(8):464-466.
5、 武变荣. 放射性粒子125I植入联合化疗治疗非小细胞肺癌的临床观察[J]. 广州医药, 2014, 45(3):17-19. 武变荣. 放射性粒子125I植入联合化疗治疗非小细胞肺癌的临床观察[J]. 广州医药, 2014, 45(3):17-19.
6、 Rossi G, Mengoli MC, Cavazza A, et al. Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology[J]. Virchows Arch,2014, 464(1):61-68. Rossi G, Mengoli MC, Cavazza A, et al. Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology[J]. Virchows Arch,2014, 464(1):61-68.
7、 孟宇宏,译.肺、胸膜、胸腺及心脏肿瘤病理学和遗传学(WHO 肿瘤分类及诊断标准系列)[M]. 北京:人民卫生出版社,2006: 44-52. 孟宇宏,译.肺、胸膜、胸腺及心脏肿瘤病理学和遗传学(WHO 肿瘤分类及诊断标准系列)[M]. 北京:人民卫生出版社,2006: 44-52.
8、 Ho JC, Wong MP, Lam WK. Lymphoepithelioma-like carcinoma of the lung[J]. Respirology, 2006, 11(5):539-545. Ho JC, Wong MP, Lam WK. Lymphoepithelioma-like carcinoma of the lung[J]. Respirology, 2006, 11(5):539-545.
9、 Huang CJ, Feng AC, Fang YF, et al.Multimodality treatment and long-term follow-up of the primary pulmonary lymphoepithelioma-like carcinoma[J]. Clin Lung Cancer. 2012, 13(5):359-62. Huang CJ, Feng AC, Fang YF, et al.Multimodality treatment and long-term follow-up of the primary pulmonary lymphoepithelioma-like carcinoma[J]. Clin Lung Cancer. 2012, 13(5):359-62.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录